doi:10.3969/j.issn.1673-8640.2025.02.011

Abstract

CLC Number:

R446.7

Figures/Tables 6

References 17

[1]	中国医师协会生殖医学专业委员会, 中国医师协会医学遗传医师分会. 单基因病胚胎着床前遗传学检测专家共识[J]. 中华生殖与避孕杂志, 2021, 41(6):477-485.
[2]	CARVALHO F, COONEN E, GOOSSENS V, et al. ESHRE PGT Consortium good practice recommendations for the organisation of PGT[J]. Hum Reprod Open, 2020, 2020(3):hoaa021.
[3]	LI X, HUANG Q, ZHONG F, et al. Preimplantation genetic testing for inborn errors of metabolism:observations from a reproductive genetic laboratory in China[J]. J Hum Genet, 2024,25.
[4]	XU J J, LI H F, WU Z Y. Paroxysmal kinesigenic dyskinesia:genetics and pathophysiological mechanisms[J]. Neurosci Bull, 2024, 40(7):952-962.
[5]	CAO L, HUANG X, WANG N, et al. Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia:an expert consensus in China[J]. Transl Neurodegener, 2021, 10(1):7.
[6]	VALENTE P, CASTROFLORIO E, ROSSI P, et al. PRRT2 is a key component of the Ca(2+)-dependent neurotransmitter release machinery[J]. Cell Rep, 2016, 15(1):117-131. DOI PMID
[7]	LIU Y T, NIAN F S, CHOU W J, et al. PRRT2 mutations lead to neuronal dysfunction and neurodevelopmental defects[J]. Oncotarget, 2016, 7(26):39184-39196.
[8]	FRUSCIONE F, VALENTE P, STERLINI B, et al. PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity[J]. Brain, 2018, 141(4):1000-1016. DOI PMID
[9]	RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
[10]	THORNHILL A R, DEDIE-SMULDERS C E, GERAEDTS J P, et al. ESHRE PGD Consortium 'best practice guidelines for clinical preimplantation genetic diagnosis(PGD)and preimplantation genetic screening(PGS)'[J]. Hum Reprod, 2005, 20(1):35-48.
[11]	《胚胎植入前遗传学诊断/筛查专家共识》编写组. 胚胎植入前遗传学诊断/筛查技术专家共识[J]. 中华医学遗传学杂志, 2018, 35(2):151-155.
[12]	EBRAHIMI-FAKHARI D, SAFFARI A, WESTENBERGER A, et al. The evolving spectrum of PRRT2-associated paroxysmal diseases[J]. Brain, 2015, 138(Pt 12):3476-3495.
[13]	SHEERIN U M, STAMELOU M, CHARLESWORTH G, et al. Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation[J]. J Neurol, 2013, 260(2):656-660.
[14]	CAO L, HUANG X J, ZHENG L, et al. Identification of a novel PRRT2 mutation in patients with paroxysmal kinesigenic dyskinesias and c.649dupC as a mutation hot-spot[J]. Parkinsonism Relat Disord, 2012, 18(5):704-706.
[15]	LI J, ZHU X, WANG X, et al. Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis[J]. J Med Genet, 2012, 49(2):76-78.
[16]	HATTA D, MAKIYA S, KANAMOTO K, et al. Proline-rich transmembrane protein 2 regulates the magnitude and frequency of dopamine release by repetitive neuronal stimuli in the striatum of L-dopa-treated mice[J]. Neuropsychopharmacol Rep, 2024, 44(4):829-834.
[17]	ZHANG Y, REN J, YANG T, et al. Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia[J]. Ther Adv Neurol Disord, 2024,17:17562864231224110.

囊胚编号	形态学评级	CNV检测结果	CNV结果解释	异倍体检测结果	致病变异携带情况
1	B4aa	dup（13）（q11q21.31）（~45.20 Mb，~42%）	嵌合异常	未见异常	不携带
3	B4ab	-21（~37%）	嵌合异常	未见异常	携带
9	B3bb	dup（1）（q32.1q44）（~46.65 Mb）	异常	未见异常	携带
12	B3ab	整倍体	未见异常	未见异常	不携带
14	B3ab	整倍体	未见异常	未见异常	不携带
2	B4bb	整倍体	未见异常	未见异常	携带
7	B4bc	整倍体	未见异常	未见异常	携带

囊胚编号	形态学评级	CNV检测结果	CNV结果解释	异倍体检测结果	致病变异携带情况
1	B4aa	dup（13）（q11q21.31）（~45.20 Mb，~42%）	嵌合异常	未见异常	不携带
3	B4ab	-21（~37%）	嵌合异常	未见异常	携带
9	B3bb	dup（1）（q32.1q44）（~46.65 Mb）	异常	未见异常	携带
12	B3ab	整倍体	未见异常	未见异常	不携带
14	B3ab	整倍体	未见异常	未见异常	不携带
2	B4bb	整倍体	未见异常	未见异常	携带
7	B4bc	整倍体	未见异常	未见异常	携带

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 17

Related Articles 15

Recommended Articles

Metrics

[1]	WANG Binbin, LI Fengqi, GUO Fenglian, ZHANG Rui, KANG Huihui, WANG Yuetong. Clinical characteristic and genetic analysis of a new mutation of SF3B4 gene causing neonatal acrofacial dysostosis 1，Nager type [J]. Laboratory Medicine, 2025, 40(2): 142-147.
[2]	BAO Yun, YU Tingting, QUAN Jing, YIN Liufan, ZHANG Pengyin, XIAO Yanqun. Result analysis of external quality assessment of next-generation sequencing for genetic testing of inherited diseases in Shanghai [J]. Laboratory Medicine, 2025, 40(2): 160-164.
[3]	TANG Jiemei, WANG Binbin, LIU Na, TANG Gusheng. Influence of concomitant gene mutation on acute myeloid leukemia patients with RUNX1::RUNX1T1 fusion [J]. Laboratory Medicine, 2025, 40(2): 186-191.
[4]	LI Bo, XIA Yongquan, SHEN Ping, XIA Mao, ZENG Jiawei. Mechanisms of cancer-associated thrombosis [J]. Laboratory Medicine, 2025, 40(2): 192-196.
[5]	SHEN Ximin, ZHANG Lei, QUAN Heng, NIU Ziguang, XIA Dongge, ZHANG Rulin. Clinical significance of serum lncRNA NEAT1 for multiple myeloma patients with kidney injury [J]. Laboratory Medicine, 2025, 40(1): 32-36.
[6]	KANG Yi, ZHANG Qiaoling, SHI Yanfang, WANG Yujia, CHEN Xiaodan, PENG Youqun. Roles of serum miR-181b and miR-144 expressions in early neurological deterioration in patients with acute ischemic stroke [J]. Laboratory Medicine, 2025, 40(1): 73-78.
[7]	LIU Ru, ZHANG Feifei, WANG Yu, LI Xin. Relationship between serum miR-9-5p，miR-185-5p expressions and cardiac function and ventricular remodeling in patients with ischemic heart failure [J]. Laboratory Medicine, 2024, 39(11): 1060-1065.
[8]	SHANG Yuanjiang, ZHU Guoqing, ZHANG Lei, SHEN Dandan, PAN Qiuhui. Application of metagenomic next-generation sequencing and traditional methods in central nervous system infection [J]. Laboratory Medicine, 2024, 39(11): 1101-1107.
[9]	LIU Jian, XU Hui, YANG Yongqiong, DENG Zhengbo. Roles of serum miR-129-3p and miR-144-3p in drug-resistant pulmonary tuberculosis patients [J]. Laboratory Medicine, 2024, 39(11): 1113-1117.
[10]	LIANG Liang, YANG Haiqing, LI Yashan, WANG Jian, MAN Baohua, TANG Haixian, ZHANG Xiaojun, HE Sai, YIN Yan. Clinical roles of miR-21，miR-222，miR-146b and miR-7 in diagnosis of papillary thyroid carcinoma [J]. Laboratory Medicine, 2024, 39(11): 1027-1034.
[11]	LIU Junru, LI Meng, XU Yang, ZHENG Weiying. Roles of urinary exosome miR-27a，miR-27b，miR-29c，miR-200c in diagnosis of early diabetic nephropathy [J]. Laboratory Medicine, 2024, 39(11): 1053-1059.
[12]	XIE Xin, SHI Lihuan, FAN Pengkai, CHEN Jing. Relation of core-binding factor acute myeloid leukemia associated with KIT mutation in children and clinical characteristics and prognosis [J]. Laboratory Medicine, 2024, 39(10): 1010-1014.
[13]	WANG Zhaohui, ZHENG Zhenlu, LI Ruina, MA Yuanyuan, XU Hui, WEI Zhenhong, JIA Yanjuan, QI Xiaoming, GAO Xiaoling. Study of latent tuberculosis infection mechanism of DosR antigen Rv2626c inducing macrophage activation through lncRNA MacORIS [J]. Laboratory Medicine, 2024, 39(10): 923-932.
[14]	LIU Jianxing, WANG Jinpeng, GENG Xinlong, WANG Shan. Role of urinary exosome miR-214 expression in diagnosis and prognosis assessment of clear cell renal cell carcinoma [J]. Laboratory Medicine, 2024, 39(10): 969-974.
[15]	ZHANG Shiqiu, LÜ Jie, YU Rong, WANG Chuanling, LIN Ziyan, ZHU Yongjun. Screening and preliminary verification of differentially expressed genes related to chronic kidney disease based on GEO database [J]. Laboratory Medicine, 2024, 39(10): 975-984.